Sasinee J Bhosai, NP
Nurse Practitioner · Glendora
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 8 years
- Graduated 2018
Offices
2 locations · William Gillespie and Associates Inc · Dr Jacob and Associates Inc
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Sasinee J Bhosai’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$32,987
Medicare paid this office $32,987 for 273 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 96 | $11,825 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $5,574 | $121 |
| Residence visit for established patient with straightforward medical decision making, per day at least 15 minutes | 48 | $3,382 | $30 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 54 | $3,248 | $56 |
| Hospital discharge day management, 30 minutes or less | 51 | $3,216 | $56 |
See all 6 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 96 | $11,825 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $5,574 | $121 |
| Residence visit for established patient with straightforward medical decision making, per day at least 15 minutes | 48 | $3,382 | $30 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 54 | $3,248 | $56 |
| Hospital discharge day management, 30 minutes or less | 51 | $3,216 | $56 |
| Short return visit (20+ min) | 16 | $2,351 | $49 |
Who their Medicare patients are
273 Original Medicare patients in 2024. Average age 69 · Under 65 35% · 85 and older 18% · Women 55% · Also on Medicaid 89% · Health risk score 2.48. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Depression 75% · Diabetes 53% · Dementia 42% · COPD 39% · Chronic kidney disease 36% · Heart failure 34% · Coronary heart disease 32% · Atrial fibrillation 19% · Stroke 16% · Cancer 7%.
The office billed $104,665, Medicare allowed $43,870 and paid $32,987; for 617 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 273 | 617 | 69 | 2.48 | $104,665 | $32,987 |
| 2023 | 301 | 1,075 | 70 | 2.37 | $166,769 | $56,011 |
| 2022 | 378 | 1,430 | 72 | 2.84 | $243,772 | $80,305 |
| 2021 | 233 | 757 | 72 | 2.72 | $120,833 | $44,579 |
| 2020 | 25 | 93 | 59 | 1.49 | $13,423 | $5,130 |
| 2019 | 182 | 506 | 60 | 2.50 | $96,822 | $35,125 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 122 | $22,656 | $52 |
| Residence visit for established patient with straightforward medical decision making, per day at least 15 minutes | 75 | $9,576 | $29 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $5,681 | $124 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 73 | $4,682 | $58 |
| Return visit (30+ min) | 14 | $3,003 | $77 |
| Psychiatric diagnostic evaluation with medical services | 20 | $2,898 | $138 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 12 | $2,220 | $131 |
| Hospital discharge day management, 30 minutes or less | 29 | $1,916 | $58 |
| Short return visit (20+ min) | 11 | $1,462 | $47 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 17 | $1,236 | $54 |
2022: 7 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 197 | $37,490 | $48 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 64 | $17,581 | $63 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 145 | $9,687 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,095 | $141 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 14 | $2,669 | $48 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,656 | $52 |
| New patient custodial care facility, group care, or assisted living visit, typically 20 minutes | 29 | $1,025 | $35 |
2021: 6 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 117 | $17,107 | $50 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 41 | $13,833 | $70 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 56 | $3,985 | $65 |
| Short return visit (20+ min) | 11 | $2,369 | $59 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 11 | $1,880 | $51 |
| New patient custodial care facility, group care, or assisted living visit, typically 20 minutes | 19 | $754 | $40 |
2020: 2 services
| Return visit (30+ min) | 21 | $3,342 | $68 |
| Short return visit (20+ min) | 13 | $1,531 | $55 |
2019: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 128 | $18,278 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $6,394 | $52 |
| Return visit (30+ min) | 21 | $4,272 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,560 | $98 |
| Hospital discharge day management, 30 minutes or less | 14 | $744 | $53 |
Medicaid work
$534 in 2024
Medicaid paid $534 for 45 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 31 | $405 |
| HOME/RES VST EST SF MDM 20 | 14 | $129 |
| 2024 | 45 | 2 | 15 | $534 |
| 2023 | 194 | 2 | 24 | $1,402 |
| 2022 | 323 | 3 | 28 | $6,381 |
| 2021 | 13 | 1 | 13 | $40 |
See the largest Medicaid services in earlier years
2023
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 95 | $727 |
| HOME/RES VST EST SF MDM 20 | 99 | $675 |
2022
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 248 | $3,766 |
| INITIAL NURSING FACILITY CARE SF/LOW MDM 25 MIN | 21 | $1,521 |
| DOM/R-HOME E/M EST PT LW MOD SEVERITY 25 MINUTES | 54 | $1,094 |
2021
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 13 | $40 |
Drugs they prescribed that Part D paid
$302,018
Pharmacies billed $302,018 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,286) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
4,025 generic and 261 brand-name prescriptions · $302,018 in drug cost · 565 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rexulti | 57 | $56,947 | $999 |
| Invega Sustenna | 13 | $43,828 | $3,371 |
| Lybalvi | 12 | $21,666 | $1,806 |
| Caplyta | 11 | $20,840 | $1,895 |
| Trintellix | 68 | $20,040 | $295 |
See all 49 drugs
| Rexulti | 57 | $56,947 | $999 |
| Invega Sustenna | 13 | $43,828 | $3,371 |
| Lybalvi | 12 | $21,666 | $1,806 |
| Caplyta | 11 | $20,840 | $1,895 |
| Trintellix | 68 | $20,040 | $295 |
| Lurasidone | 25 | $9,531 | $381 |
| Aripiprazole | 149 | $6,883 | $46 |
| Risperidone Odt | 20 | $2,694 | $135 |
| Chlorpromazine | 11 | $2,612 | $237 |
| Duloxetine | 119 | $2,503 | $21 |
| Olanzapine | 140 | $2,440 | $17 |
| Quetiapine | 232 | $2,305 | $10 |
| Bupropion Xl | 151 | $2,176 | $14 |
| Escitalopram | 416 | $1,912 | $5 |
| Trazodone | 374 | $1,879 | $5 |
| Olanzapine Odt | 25 | $1,297 | $52 |
| Paroxetine Er | 26 | $1,134 | $44 |
| Risperidone | 90 | $1,096 | $12 |
| Mirtazapine | 173 | $1,075 | $6 |
| Paroxetine Cr | 40 | $1,057 | $26 |
| Divalproex | 92 | $1,025 | $11 |
| Perphenazine | 11 | $969 | $88 |
| Divalproex Sodium Er | 23 | $923 | $40 |
| Lorazepam | 161 | $887 | $6 |
| Guanfacine Hcl Er | 20 | $877 | $44 |
| Sertraline | 224 | $860 | $4 |
| Fluphenazine | 15 | $813 | $54 |
| Ramelteon | 47 | $734 | $16 |
| Clonazepam | 116 | $728 | $6 |
| Fluoxetine | 89 | $718 | $8 |
| Venlafaxine Hcl Er | 66 | $641 | $10 |
| Memantine | 74 | $632 | $9 |
| Donepezil | 153 | $612 | $4 |
| Benztropine Mesylate | 78 | $557 | $7 |
| Zolpidem | 65 | $515 | $8 |
| Citalopram Hbr | 164 | $498 | $3 |
| Alprazolam | 126 | $480 | $4 |
| Modafinil | 12 | $464 | $39 |
| Lithium Carbonate | 20 | $447 | $22 |
| Venlafaxine | 18 | $439 | $24 |
| Hydroxyzine | 33 | $432 | $13 |
| Hydroxyzine Pamoate | 29 | $430 | $15 |
| Buspirone | 88 | $420 | $5 |
| Haloperidol | 15 | $355 | $24 |
| Paroxetine | 110 | $324 | $3 |
| Bupropion Hcl Sr | 14 | $317 | $23 |
| Lamotrigine | 53 | $301 | $6 |
| Temazepam | 45 | $296 | $7 |
| Quetiapine Fumarate Er | 46 | $263 | $6 |
Year by year
| 2024 | 4,286 | 202 | 0% (0) | 6% | $302,018 |
| 2023 | 4,089 | 202 | 0% (0) | 6% | $344,622 |
| 2022 | 2,586 | 192 | None | 5% | $365,869 |
| 2021 | 2,009 | 172 | 0% (0) | 6% | $268,507 |
| 2020 | 1,193 | 105 | 0% (0) | 8% | $156,489 |
| 2019 | 1,126 | 92 | None | 10% | $142,764 |
| 2018 | 81 | 17 | 0% (0) | 16% | $7,389 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Invega Sustenna | 14 | $48,393 | $3,457 |
| Rexulti | 52 | $39,480 | $759 |
| Vraylar | 21 | $31,285 | $1,490 |
| Trintellix | 47 | $20,695 | $440 |
| Aripiprazole | 75 | $16,533 | $220 |
| Modafinil | 13 | $10,552 | $812 |
| Memantine | 205 | $7,453 | $36 |
| Olanzapine | 93 | $6,122 | $66 |
| Lexapro | 23 | $4,793 | $208 |
| Bupropion Xl | 164 | $4,678 | $29 |
| Duloxetine | 144 | $4,595 | $32 |
| Divalproex Sodium Er | 30 | $3,994 | $133 |
| Viibryd | 11 | $3,897 | $354 |
| Escitalopram | 436 | $3,871 | $9 |
| Quetiapine | 232 | $3,688 | $16 |
| Trazodone | 262 | $3,332 | $13 |
| Chlorpromazine | 13 | $3,201 | $246 |
| Quetiapine Fumarate Er | 34 | $3,100 | $91 |
| Lurasidone | 16 | $3,066 | $192 |
| Divalproex | 57 | $2,185 | $38 |
| Donepezil | 275 | $2,134 | $8 |
| Olanzapine Odt | 27 | $2,126 | $79 |
| Bupropion Hcl Sr | 14 | $1,875 | $134 |
| Sertraline | 236 | $1,748 | $7 |
| Risperidone | 86 | $1,578 | $18 |
| Mirtazapine | 118 | $1,563 | $13 |
| Perphenazine | 12 | $1,457 | $121 |
| Ramelteon | 11 | $1,431 | $130 |
| Lorazepam | 175 | $1,271 | $7 |
| Dextroamphetamine-Amphet Er | 21 | $1,233 | $59 |
| Fluoxetine | 75 | $1,211 | $16 |
| Clonazepam | 144 | $1,149 | $8 |
| Paroxetine Er | 16 | $918 | $57 |
| Hydroxyzine | 59 | $908 | $15 |
| Benztropine Mesylate | 61 | $816 | $13 |
| Venlafaxine Hcl Er | 42 | $722 | $17 |
| Hydroxyzine Pamoate | 35 | $662 | $19 |
| Alprazolam | 123 | $658 | $5 |
| Pregabalin | 12 | $648 | $54 |
| Vilazodone | 20 | $618 | $31 |
| Buspirone | 77 | $618 | $8 |
| Venlafaxine | 27 | $603 | $22 |
| Citalopram Hbr | 109 | $564 | $5 |
| Lithium Carbonate | 18 | $494 | $27 |
| Zolpidem | 57 | $489 | $9 |
| Paroxetine | 79 | $457 | $6 |
| Temazepam | 50 | $342 | $7 |
| Lamotrigine | 16 | $266 | $17 |
| Fluphenazine | 12 | $202 | $17 |
2022: 46 drugs
| Ingrezza | 11 | $80,672 | $7,334 |
| Invega Sustenna | 15 | $46,456 | $3,097 |
| Aristada | 15 | $42,575 | $2,838 |
| Latuda | 20 | $41,832 | $2,092 |
| Aripiprazole | 67 | $16,851 | $252 |
| Trintellix | 26 | $15,661 | $602 |
| Rexulti | 11 | $14,227 | $1,293 |
| Modafinil | 12 | $10,505 | $875 |
| Chlorpromazine | 11 | $7,231 | $657 |
| Olanzapine | 79 | $6,497 | $82 |
| Quetiapine Fumarate Er | 19 | $4,263 | $224 |
| Memantine | 80 | $3,916 | $49 |
| Fluphenazine | 11 | $3,698 | $336 |
| Doxepin | 18 | $3,513 | $195 |
| Escitalopram | 244 | $3,279 | $13 |
| Bupropion Xl | 134 | $3,154 | $24 |
| Trazodone | 160 | $2,905 | $18 |
| Quetiapine | 112 | $2,746 | $25 |
| Olanzapine Odt | 16 | $2,708 | $169 |
| Divalproex Sodium Er | 18 | $2,671 | $148 |
| Duloxetine | 63 | $2,572 | $41 |
| Divalproex | 38 | $2,154 | $57 |
| Lorazepam | 198 | $2,004 | $10 |
| Risperidone Odt | 12 | $1,953 | $163 |
| Bupropion Hcl Sr | 14 | $1,866 | $133 |
| Risperidone | 94 | $1,459 | $16 |
| Donepezil | 103 | $1,209 | $12 |
| Fluoxetine | 52 | $1,192 | $23 |
| Atomoxetine | 12 | $1,073 | $89 |
| Mirtazapine | 58 | $1,039 | $18 |
| Dextroamphetamine-Amphet Er | 22 | $914 | $42 |
| Oxcarbazepine | 15 | $806 | $54 |
| Sertraline | 101 | $750 | $7 |
| Clonazepam | 110 | $735 | $7 |
| Benztropine Mesylate | 58 | $726 | $13 |
| Haloperidol | 18 | $678 | $38 |
| Venlafaxine Hcl Er | 30 | $652 | $22 |
| Alprazolam | 115 | $643 | $6 |
| Hydroxyzine Pamoate | 22 | $574 | $26 |
| Hydroxyzine | 23 | $474 | $21 |
| Zolpidem | 62 | $391 | $6 |
| Lithium Carbonate | 25 | $381 | $15 |
| Buspirone | 25 | $347 | $14 |
| Citalopram Hbr | 35 | $344 | $10 |
| Temazepam | 47 | $320 | $7 |
| Paroxetine | 19 | $162 | $9 |
2021: 40 drugs
| Aristada | 35 | $86,964 | $2,485 |
| Invega Sustenna | 14 | $42,568 | $3,041 |
| Latuda | 21 | $33,548 | $1,598 |
| Fluphenazine | 12 | $6,390 | $533 |
| Aripiprazole | 62 | $4,118 | $66 |
| Bupropion Xl | 86 | $3,051 | $35 |
| Divalproex Sodium Er | 19 | $3,022 | $159 |
| Memantine | 36 | $2,366 | $66 |
| Quetiapine | 106 | $2,198 | $21 |
| Olanzapine | 47 | $2,005 | $43 |
| Duloxetine | 41 | $1,951 | $48 |
| Fluoxetine | 66 | $1,789 | $27 |
| Trazodone | 153 | $1,780 | $12 |
| Escitalopram | 139 | $1,649 | $12 |
| Atomoxetine | 16 | $1,526 | $95 |
| Dextroamphetamine-Amphet Er | 28 | $1,522 | $54 |
| Olanzapine Odt | 15 | $1,481 | $99 |
| Perphenazine | 12 | $1,419 | $118 |
| Risperidone | 85 | $1,257 | $15 |
| Lorazepam | 151 | $1,205 | $8 |
| Clonazepam | 112 | $1,090 | $10 |
| Oxcarbazepine | 21 | $947 | $45 |
| Venlafaxine Hcl Er | 30 | $841 | $28 |
| Donepezil | 71 | $837 | $12 |
| Mirtazapine | 46 | $779 | $17 |
| Benztropine Mesylate | 50 | $758 | $15 |
| Sertraline | 46 | $455 | $10 |
| Alprazolam | 94 | $422 | $4 |
| Bupropion Hcl Sr | 20 | $421 | $21 |
| Zolpidem | 56 | $330 | $6 |
| Modafinil | 13 | $328 | $25 |
| Buspirone | 19 | $325 | $17 |
| Divalproex | 19 | $311 | $16 |
| Temazepam | 42 | $291 | $7 |
| Hydroxyzine Pamoate | 15 | $275 | $18 |
| Lithium Carbonate | 12 | $249 | $21 |
| Citalopram Hbr | 18 | $128 | $7 |
| Paroxetine | 11 | $108 | $10 |
| Propranolol | 26 | $107 | $4 |
| Hydroxyzine | 11 | $104 | $9 |
2020: 30 drugs
| Latuda | 20 | $41,550 | $2,078 |
| Bupropion Xl | 64 | $1,972 | $31 |
| Atomoxetine | 23 | $1,851 | $80 |
| Aripiprazole | 38 | $1,804 | $47 |
| Haloperidol | 28 | $1,320 | $47 |
| Modafinil | 13 | $1,123 | $86 |
| Quetiapine | 64 | $1,063 | $17 |
| Duloxetine | 30 | $1,059 | $35 |
| Venlafaxine Hcl Er | 29 | $821 | $28 |
| Trazodone | 89 | $775 | $9 |
| Dextroamphetamine-Amphet Er | 16 | $774 | $48 |
| Escitalopram | 78 | $736 | $9 |
| Clonazepam | 62 | $724 | $12 |
| Fluoxetine | 49 | $715 | $15 |
| Mirtazapine | 28 | $622 | $22 |
| Oxcarbazepine | 21 | $580 | $28 |
| Olanzapine | 34 | $534 | $16 |
| Benztropine Mesylate | 33 | $363 | $11 |
| Gabapentin | 16 | $343 | $21 |
| Sertraline | 23 | $342 | $15 |
| Bupropion Hcl Sr | 13 | $341 | $26 |
| Risperidone | 33 | $275 | $8 |
| Alprazolam | 58 | $261 | $4 |
| Hydroxyzine Pamoate | 19 | $222 | $12 |
| Lorazepam | 43 | $213 | $5 |
| Lithium Carbonate | 27 | $207 | $8 |
| Zolpidem | 33 | $204 | $6 |
| Buspirone | 13 | $178 | $14 |
| Temazepam | 16 | $125 | $8 |
| Citalopram Hbr | 17 | $53 | $3 |
2019: 30 drugs
| Latuda | 25 | $34,273 | $1,371 |
| Trintellix | 20 | $8,646 | $432 |
| Aripiprazole | 42 | $3,828 | $91 |
| Duloxetine | 61 | $1,744 | $29 |
| Bupropion Xl | 29 | $944 | $33 |
| Quetiapine | 105 | $929 | $9 |
| Modafinil | 15 | $869 | $58 |
| Hydroxyzine Pamoate | 54 | $596 | $11 |
| Trazodone | 57 | $556 | $10 |
| Escitalopram | 61 | $547 | $9 |
| Haloperidol | 22 | $494 | $22 |
| Fluvoxamine Maleate | 11 | $491 | $45 |
| Clonazepam | 58 | $460 | $8 |
| Risperidone | 68 | $447 | $7 |
| Olanzapine | 30 | $440 | $15 |
| Bupropion Hcl Sr | 25 | $406 | $16 |
| Venlafaxine Hcl Er | 18 | $305 | $17 |
| Alprazolam | 42 | $266 | $6 |
| Lorazepam | 44 | $259 | $6 |
| Mirtazapine | 15 | $199 | $13 |
| Zolpidem | 29 | $198 | $7 |
| Oxcarbazepine | 11 | $181 | $16 |
| Buspirone | 19 | $158 | $8 |
| Divalproex | 18 | $150 | $8 |
| Sertraline | 21 | $140 | $7 |
| Benztropine Mesylate | 22 | $139 | $6 |
| Fluoxetine | 23 | $125 | $5 |
| Lithium Carbonate | 21 | $123 | $6 |
| Temazepam | 16 | $85 | $5 |
| Citalopram Hbr | 16 | $76 | $5 |
Money from drug and device companies
$1,305 in 2025
| 2025 | 8 | 29 | None | $1,305 |
| 2024 | 12 | 28 | None | $969 |
| 2023 | 13 | 117 | None | $2,036 |
| 2022 | 14 | 117 | None | $1,951 |
| 2021 | 17 | 170 | None | $2,886 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | Uzedy | $474 | 5 payments
|
| Alkermes | Aristada | $268 | 8 payments
|
| Axsome Therapeutics | Auvelity | $200 | 4 payments
|
| Otsuka America Pharmaceutical | Rexulti | $164 | 3 payments
|
| Abbvie | Vraylar | $62 | 4 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $59 | 2 payments
|
See all 29 published payments
| Abbvie | Meals · 2025-12-15 | Vraylar | $14 |
| Neurocrine BioSciences | Meals · 2025-11-19 | Ingrezza | $37 |
| Neurocrine BioSciences | Meals · 2025-11-05 | Ingrezza | $20 |
| Otsuka America Pharmaceutical | Meals · 2025-11-03 | Rexulti | $19 |
| Janssen Pharmaceuticals | Meals · 2025-10-24 | Invega Sustenna | $35 |
| Janssen Pharmaceuticals | Meals · 2025-10-20 | Invega Sustenna | $24 |
| Abbvie | Meals · 2025-09-22 | Vraylar | $19 |
| Teva Pharmaceuticals USA | Meals · 2025-09-09 | Uzedy | $24 |
| Teva Pharmaceuticals USA | Meals · 2025-08-20 | Austedo Xr | $122 |
| Abbvie | Meals · 2025-07-29 | Vraylar | $14 |
| Alkermes | Meals · 2025-07-29 | Aristada | $3 |
| Alkermes | Meals · 2025-07-29 | Aristada | $27 |
| Abbvie | Meals · 2025-07-18 | Vraylar | $15 |
| Alkermes | Meals · 2025-05-29 | Lybalvi | $123 |
| Axsome Therapeutics | Meals · 2025-05-13 | Auvelity | $23 |
| Alkermes | Meals · 2025-05-10 | Aristada | $21 |
| Teva Pharmaceuticals USA | Meals · 2025-05-07 | Uzedy | $99 |
| Otsuka America Pharmaceutical | Meals · 2025-05-06 | Rexulti | $20 |
| Teva Pharmaceuticals USA | Education · 2025-04-08 | None | $104 |
| Alkermes | Meals · 2025-04-01 | Aristada | $22 |
| Axsome Therapeutics | Meals · 2025-04-01 | Auvelity | $24 |
| Otsuka America Pharmaceutical | Meals · 2025-02-26 | Rexulti | $125 |
| Alkermes | Meals · 2025-02-25 | Aristada | $13 |
| Axsome Therapeutics | Meals · 2025-02-25 | Auvelity | $31 |
| Teva Pharmaceuticals USA | Meals · 2025-02-19 | Uzedy | $124 |
| Alkermes | Meals · 2025-02-15 | Aristada | $42 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-05 | Caplyta | $21 |
| Axsome Therapeutics | Meals · 2025-01-28 | Auvelity | $122 |
| Alkermes | Meals · 2025-01-14 | Aristada | $17 |
See earlier years (2024, 2023, 2022, 2021)
2024: $969
| E.R. Squibb & Sons L.L.C. | Cobenfy | $289 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $156 | 4 payments
|
| Teva Pharmaceuticals USA | Uzedy | $134 | 5 payments
|
| Lundbeck | Rexulti | $106 | 5 payments
|
| Abbvie | Vraylar | $82 | 3 payments
|
| Indivior | Perseris | $62 | 3 payments
|
| Vanda Pharmaceuticals | Hetlioz | $32 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $31 | 1 payment
|
| Alkermes | Aristada | $25 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $20 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $19 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $14 | 1 payment
|
2023: $2,036
| Abbvie | Vraylar | $524 | 28 payments
|
| Teva Pharmaceuticals USA | Uzedy | $329 | 12 payments
|
| Alkermes | Aristada | $282 | 15 payments
|
| Otsuka America Pharmaceutical | Rexulti | $208 | 10 payments
|
| Lundbeck | Abilify Maintena | $178 | 11 payments
|
| Iti | Caplyta | $159 | 20 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $149 | 11 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $71 | 3 payments
|
| Indivior | Perseris | $43 | 2 payments
|
| Supernus Pharmaceuticals | Qelbree | $30 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $25 | 1 payment
|
| Bausch Health US | Aplenzin | $23 | 1 payment
|
| Vanda Pharmaceuticals | Hetlioz | $13 | 1 payment
|
2022: $1,951
| Sunovion Pharmaceuticals | Latuda | $470 | 26 payments
|
| Abbvie | Vraylar | $447 | 26 payments
|
| Alkermes | Aristada | $239 | 13 payments
|
| Iti | Caplyta | $185 | 17 payments
|
| Teva Pharmaceuticals USA | Austedo | $179 | 14 payments
|
| Supernus Pharmaceuticals | Qelbree | $140 | 7 payments
|
| Otsuka America Pharmaceutical | Rexulti | $67 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $48 | 2 payments
|
| Almatica Pharma | Gralise | $47 | 2 payments
|
| Vanda Pharmaceuticals | Hetlioz | $44 | 2 payments
|
| Indivior | Perseris | $29 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $24 | 1 payment
|
| Bausch Health US | Aplenzin | $19 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $15 | 1 payment
|
2021: $2,886
| AbbVie | Vraylar | $497 | 30 payments
|
| Teva Pharmaceuticals USA | Austedo | $352 | 19 payments
|
| Sunovion Pharmaceuticals | Latuda | $298 | 18 payments
|
| Lundbeck | Abilify Maintena | $291 | 19 payments
|
| Neurocrine Biosciences | Ingrezza | $280 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $244 | 20 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $194 | 13 payments
|
| Alkermes | Aristada | $133 | 10 payments
|
| Iti | Caplyta | $121 | 8 payments
|
| Eisai | Dayvigo | $115 | 12 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $95 | 4 payments
|
| Indivior | Perseris | $86 | 5 payments
|
| Bausch Health US | Aplenzin | $57 | 3 payments
|
| Vanda Pharmaceuticals | Hetlioz | $54 | 2 payments
|
| Supernus Pharmaceuticals | Qelbree | $34 | 2 payments
|
| Noven Therapeutics | Secuado | $18 | 1 payment
|
| Adlon Therapeutics L.P. | Adhansia Xr | $17 | 1 payment
|
Professional record
- NPI
- 1033691316
- Licence
- CA 95009894
- Group
- William Gillespie and Associates Inc · Dr Jacob and Associates Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 1626 Montana Ave # 645, Santa Monica, CA, 90403
- NPI first listed
- 2018-09-03
- NPI last updated
- 2025-10-03
- NPI record certified
- 2025-10-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 415 W Route 66 Ste 202, Glendora, CA, 91740